- Home
- ESEA vs INBX Comparison
ESEA vs INBX Comparison
Compare ESEA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- INBX
- Stock Information
- Founded
- ESEA 2005
- INBX 2010
- Country
- ESEA Greece
- INBX United States
- Employees
- ESEA N/A
- INBX N/A
- Industry
- ESEA Marine Transportation
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- INBX Health Care
- Exchange
- ESEA Nasdaq
- INBX Nasdaq
- Market Cap
- ESEA 208.2M
- INBX 178.5M
- IPO Year
- ESEA 2006
- INBX 2020
- Fundamental
- Price
- ESEA $48.62
- INBX $21.73
- Analyst Decision
- ESEA Strong Buy
- INBX Hold
- Analyst Count
- ESEA 1
- INBX 1
- Target Price
- ESEA $62.00
- INBX N/A
- AVG Volume (30 Days)
- ESEA 50.8K
- INBX 120.3K
- Earning Date
- ESEA 08-05-2025
- INBX 08-12-2025
- Dividend Yield
- ESEA 5.33%
- INBX N/A
- EPS Growth
- ESEA 21.86
- INBX N/A
- EPS
- ESEA 18.62
- INBX 111.58
- Revenue
- ESEA $222,525,034.00
- INBX $200,000.00
- Revenue This Year
- ESEA $5.14
- INBX N/A
- Revenue Next Year
- ESEA $3.76
- INBX N/A
- P/E Ratio
- ESEA $2.54
- INBX $0.20
- Revenue Growth
- ESEA 14.62
- INBX N/A
- 52 Week Low
- ESEA $24.58
- INBX $10.80
- 52 Week High
- ESEA $50.82
- INBX $22.28
- Technical
- Relative Strength Index (RSI)
- ESEA 61.35
- INBX 84.22
- Support Level
- ESEA $46.59
- INBX $13.97
- Resistance Level
- ESEA $50.50
- INBX $15.25
- Average True Range (ATR)
- ESEA 1.84
- INBX 1.10
- MACD
- ESEA -0.13
- INBX 0.66
- Stochastic Oscillator
- ESEA 53.62
- INBX 95.32
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.